From JP Morgan Note: 1) The majority of docs we surveyed who have used Iclusig do not expect their use to change over the next 6 - 12 months. 2) Most Physicians view Iclusig's safety profile "moderately worse" vs. Tasigna. Not so bad at all... Supertramp